These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence, health care expenditures, and orthopedic surgery workforce for musculoskeletal conditions. Haralson RH; Zuckerman JD JAMA; 2009 Oct; 302(14):1586-7. PubMed ID: 19826031 [No Abstract] [Full Text] [Related]
3. A national strategy for UK musculoskeletal clinical research: Arthritis Research UK clinical studies initiative. Silman AJ; Rudkin S Rheumatology (Oxford); 2011 Apr; 50(4):640-2. PubMed ID: 20615917 [No Abstract] [Full Text] [Related]
4. 30 million, around 10 000 ... and 18 ... figuring out the optimal treatment for musculoskeletal conditions in the National Health Service. Isenberg DA Rheumatology (Oxford); 2007 Aug; 46(8):1219-20. PubMed ID: 17569748 [No Abstract] [Full Text] [Related]
5. A new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (ARC) Clinical Studies Groups initiative. Silman A Rheumatology (Oxford); 2008 Jun; 47(6):777-9. PubMed ID: 18388147 [TBL] [Abstract][Full Text] [Related]
6. Gaining approval for clinical research. Cobb V; Srinivasan N; Lambiase P Br J Hosp Med (Lond); 2016 Jul; 77(7):414-8. PubMed ID: 27388381 [TBL] [Abstract][Full Text] [Related]
7. Perspectives on the future of bone and joint diseases. McGowan JA J Rheumatol Suppl; 2003 Aug; 67():62-4. PubMed ID: 12926660 [TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal disability and rheumatology. Gordon DA; Inman RD J Rheumatol; 1994 Mar; 21(3):387. PubMed ID: 8006879 [No Abstract] [Full Text] [Related]
9. Bone and joint diseases around the world. USA: arthritis foundation research, collaboration, and advocacy. Riggin DL J Rheumatol Suppl; 2003 Aug; 67():32. PubMed ID: 12926649 [No Abstract] [Full Text] [Related]
11. US bone and joint decade prepares for the future. Jacobs JJ; King T Arthritis Rheum; 2009 Nov; 61(11):1470-1. PubMed ID: 19877083 [No Abstract] [Full Text] [Related]
12. Cost of musculoskeletal diseases: impact of work disability and functional decline. Yelin E J Rheumatol Suppl; 2003 Dec; 68():8-11. PubMed ID: 14712615 [TBL] [Abstract][Full Text] [Related]
13. The Research Network for Inflammation and Rheumatic Diseases (RIER). Pablos Álvarez JL Reumatol Clin; 2016; 12(3):121-2. PubMed ID: 26975513 [No Abstract] [Full Text] [Related]
14. Analysis of the workforce and workplace for rheumatology and the research activities of rheumatologists early in their careers. Desjardins C; St Clair EW; Ehrenberg RG Arthritis Rheum; 2010 Dec; 62(12):3528-36. PubMed ID: 20737466 [TBL] [Abstract][Full Text] [Related]
15. [Rheumatology - current and future treatment of inflammatory and non-inflammatory musculoskeletal diseases in Germany. An assessment by the board of the German Society for Rheumatology]. Braun J; Schneider M; Genth E Z Rheumatol; 2012 Sep; 71(7):544-9. PubMed ID: 22930104 [No Abstract] [Full Text] [Related]
17. Research into practice: improving musculoskeletal care in general practice. Helliwell T; Mallen C; Peat G; Hay E Br J Gen Pract; 2014 Jul; 64(624):372-4. PubMed ID: 24982489 [No Abstract] [Full Text] [Related]
18. Rheumatology in 2006: crossroads or crisis? Pisetsky DS Bull NYU Hosp Jt Dis; 2006; 64(1-2):9-11. PubMed ID: 17121482 [TBL] [Abstract][Full Text] [Related]
19. Cancer research fund launches biologics pilot plant. Subbaraman N Nat Biotechnol; 2010 Oct; 28(10):995-6. PubMed ID: 20944573 [No Abstract] [Full Text] [Related]
20. Sports and exercise medicine and rheumatology. Speed CA Rheumatology (Oxford); 2005 Feb; 44(2):143-4. PubMed ID: 15590765 [No Abstract] [Full Text] [Related] [Next] [New Search]